Belapectin is the first drug to show positive results in a clinical trial in patients with compensated NASH cirrhosis without esophageal varices, and it is with great optimism that we anticipate a fourth quarter launch of this very important trial."
Among the various possible evaluations, in clinical practice, the assessment of the presence of varices and of the extent of fibrosis in the liver and spleen are certainly the most important.
Upon endoscopy, most patients are found to harbour esophageal varices while in a minority of patients, gastric varices are the primary sites of bleeding.
Approximately 50% of the patients develop esophageal varices while a small percentage develops complications in the other part of the gastrointestinal tract like ectopic varices in the small bowel [4, 5].
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.